title: Pregnancy outcome in the setting of extremely low first trimester PAPP-A levels.
abstract: BACKGROUND
  Serum pregnancy-associated plasma protein-A (PAPP-A) is part of first trimester Down syndrome screening. Low levels have been associated with adverse outcome as well as chromosomal abnormality.
  
  
  OBJECTIVE
  To assess the incidence of adverse outcome when PAPP-A levels are at or below 0.2 multiples of the median (MoM).
  
  
  METHODS
  Data on consecutive patients attending a first trimester screening program were collected. Those with PAPP-A levels < or = 0.2 MoM were divided into three groups: < or = 0.1 MoM; 0.11-0.15 MoM; and 0.16-0.2 MoM.
  
  
  RESULTS
  Screening 44 535 patients resulted in 197 with PAPP-A levels < or = 0.2 MoM. The incidence of karyotypic abnormality increased with decreasing PAPP-A levels. In the absence of chromosome abnormality, pregnancy outcomes were defined as 'normal' in at least 30% and 'good' in at least 60%, with both percentages increasing as the PAPP-A level rose. The PAPP-A levels were significantly lower in the group with a poor outcome. The incidence of prematurity was similar in the three groups, but higher than the statewide average, while the incidence of extreme prematurity appeared to be related to reducing PAPP-A levels. The incidence of growth restriction in the three groups was similar, but was still double the incidence in the normal population.
  
  
  CONCLUSIONS
  If the PAPP-A level is < or = 0.2 MoM and the karyotype is normal, there is an increased risk of adverse outcome. Even with PAPP-A below 0.1 MoM, a good outcome can be expected in 60% of cases. Careful morphological assessment is suggested and later monitoring of fetal growth and well-being.
authors: Sydney Ultrasound for Women, Sydney, New South Wales, Australia. fergus.scott@sufw.com.au
authors: Fergus
authors: F
authors: Scott
authors: Anne
authors: A
authors: Coates
authors: Andrew
authors: A
authors: McLennan
mesh_terms: D000022:Abortion, Spontaneous; D000328:Adult; D002869:Chromosome Aberrations; D000013:Congenital Abnormalities / Q000097:blood*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007236:Infant, Small for Gestational Age; D011247:Pregnancy; D011261:Pregnancy Trimester, First / Q000097:blood*; D011266:Pregnancy-Associated Plasma Protein-A / Q000378:metabolism*; D011296:Prenatal Diagnosis; D012189:Retrospective Studies; D012307:Risk Factors; D050497:Stillbirth
chemical_list: D011266:Pregnancy-Associated Plasma Protein-A